Marine bioproducts banner

Centre for Marine Bioproducts Development

The Centre for Marine Bioproducts Development is focussed on the research and development, innovation, education and commercialisation of marine bioprocess technologies and bioproducts.

Our aim is to become a focal point in Australia with these technologies and products for sustainable and profitable seafood and functional foods, marine bioproducts and biomaterials, biomedicine, and marine biofuels industries.

The Centre is the first facility and grouping of expertise of its kind in the Southern Hemisphere. It is a bold initiative by Flinders University, one of Australia’s top research universities.

Functioning since 2007, the Centre is about creating collaborations and networks with like-minded researchers and industry partners.

Australia New Zealand Marine Biotechnology Society

The Australia New Zealand Marine Biotechnology Society (ANZMBS) is hosted by the Centre and welcomes new members. For more information please visit the website or contact us .


Rapid Production of drug delivery vehicles (nanoparticles) (Sept 2018)

Drug delivery could be made easier and cheaper by the use of nanoparticles. CMBD PhD student Xuan Luo collaborated with the Institute for Nanoscale Science and Technology to use the Vortex Fluidic Device (VFD) to create nanoparticles that can be used in drug delivery, using cheap starting materials. See Xuan explain the research in this video . For a much more detailed explanation see the publication "Vortex Fluidic Mediated Synthesis of Macroporous Bovine SerumAlbumin-Based Microspheres ".

Bio-products and Biotechnology CRC bid could be a boost for Australia's blue bio-economy (July 2018)

Flinders has recently submitted a Stage 1 proposal for the Cooperative Research Centres 20th Selection Round. The Marine Bioproducts and Biotechnology CRC is a national and international collaboration to position Australia at the cutting-edge of a high-value new industry, led by Professor Wei Zhang. Read more...

Bioactive properties of shiitake mushroom as a possible reducer of cancer treatment side-effects to be studied at CMBD (July 2018)

Flinders University biomedical researcher Dr Linlin Ma will work with the Shanxi Yulongxiang Agricultural Development Company to investigate the usefulness of more accessible and palatable use of traditional Chinese medicine (TCM) via the medium of edible shiitake mushrooms. Read more...